RE:RE:RE:What happens if question...meetoo or anyone else Here is a list of just six countries (there are more) from which the UK NHS could have secured a supply of Liothyronine at a fraction of the price that Amdipharm (now Concordia) was charging in the relevant period:
Sweden - 100 tablets of L-T3 = £21.10
Finland - 100 tablets of L-T3 = £15.81
Norway - 100 tablets of L-T3 =NOK 254.50 = 27.51€ = £21.65
Denmark - 100 tablets of L-T3 20mcgs – Thybon 20 Henning = DKK 190 = 25.53€ = £20.09
Germany -100 tablets of L-T3 20mcgs -30.15€
Turkey - 100 tablets of L-T3 – Tiromel = £1.25
There are at least 8 manufacturers worldwide. CXR did not force the NHS to take their supply, which, it does seem, was priced exorbitantly. The people at the NHS were supposed to monitor these things, but when Cinven got hold of the CXR predecessor companies and started jacking up prices, they were asleep at the switch. So the regulators are embarassed, and that has led to poltical fallout. The NHS has since acted, so the impugned conduct cannot continue.
I read recently that someone purchased a painting attributed (without proof) to Leonardo Da Vinci for US$450,000,000. Google it, you will see the same story. The article indicated that the same painting had sold for just $150 a few years earlier. Can the high seller be criminal prosecuted for overcharging? Not in my world. There was no evidence of deception. He set his price. The buyer bought. End of story.
I am not by any means an insider, but I think that the CMA has a tenuous case. It is mostly politics meant to cover up the fact that regulators were asleep at the switch. Time will pass and the investigations will be quietly discontinued. This will become a certainty if Flynn Pharma and Pfizer win their appeals.
I am not saying that what CXR or those drug companies did was morally right.